Serum IgA responses against pertussis proteins in infected and dutch wP or aP vaccinated children: An additional role in pertussis diagnostics

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Hendrikx, Lotte H ^a,b   Öztürk, Kemal ^a   de Rond, Lia G H ^a   de Greeff, Sabine C ^a   Sanders, Elisabeth A M ^c   Berbers, Guy A M ^a   Buisman, Anne Marie ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DUTCH WHOLE CELL PERTUSSIS VACCINE; HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; TRIAXIS; UNCLASSIFIED DRUG; BACTERIAL PROTEIN;

ARTICLE; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; MEMORY CELL; OUTCOME ASSESSMENT; PERTUSSIS; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY ANALYSIS; VACCINATION; B LYMPHOCYTE; BLOOD; IMMUNIZATION; IMMUNOLOGY; INFANT; METHODOLOGY; NETHERLANDS; SPECIES DIFFERENCE; TIME;

BORDETELLA PERTUSSIS;

B-LYMPHOCYTES; BACTERIAL PROTEINS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; NETHERLANDS; SPECIES SPECIFICITY; TIME FACTORS; VACCINATION; WHOOPING COUGH;

EID: 81055143761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027681     Document Type: Article

References (35)

1. Parton R, (1999) Review of the biology of Bordetella pertussis. Biologicals 27: 71-76.
2. Woof JM, Kerr MA, (2006) The function of immunoglobulin A in immunity. J Pathol 208: 270-282.
3. Nagel J, Poot-Scholtens EJ, (1983) Serum IgA antibody to Bordetella pertussis as an indicator of infection. J Med Microbiol 16: 417-426.
4. Poynten M, Hanlon M, Irwig L, Gilbert GL, (2002) Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection. Epidemiol Infect 128: 161-167.
5. Novotny P, Macaulay ME, Hart TC, Skvaril F, (1991) Analysis of antibody profiles in children with whooping cough. Dev Biol Stand 73: 267-273.
6. Heininger U, Cherry JD, Stehr K, (2004) Serologic response and antibody-titer decay in adults with pertussis. Clin Infect Dis 38: 591-594.
7. Deen JL, Mink CA, Cherry JD, Christenson PD, Pineda EF, et al. (1995) Household contact study of Bordetella pertussis infections. Clin Infect Dis 21: 1211-1219.
8. Bonhoeffer J, Bar G, Riffelmann M, Soler M, Heininger U, (2005) The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection 33: 13-17.
9. Thomas MG, Ashworth LA, Miller E, Lambert HP, (1989) Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. J Infect Dis 160: 838-845.
10. Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, et al. (2004) Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 190: 535-544.
11. Littmann M, Hulsse C, Riffelmann M, Wirsing von Konig CH, (2008) Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers. Vaccine 26: 2344-2349.
12. Knuf M, Zepp F, Meyer C, Grzegowski E, Wolter J, et al. (2006) Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population. Vaccine 24: 2043-2048.
13. Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, et al. (2010) What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis.
14. Hendrikx LH, Berbers GA, Veenhoven RH, Sanders EA, Buisman AM, (2009) IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine 27: 6530-6536.
15. de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, et al. (2010) Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 50: 1339-1345.
16. van Gageldonk PG, van Schaijk FG, van der Klis FR, Berbers GA, (2008) Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods 335: 79-89.
17. Buisman AM, de Rond CG, Ozturk K, Ten Hulscher HI, van Binnendijk RS, (2009) Long-term presence of memory B-cells specific for different vaccine components. Vaccine 28: 179-186.
18. Hendrikx LH, Ozturk K, de Rond LG, Veenhoven RH, Sanders EA, et al. (2011) Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins. Vaccine 29: 1431-1437.
19. de Greeff SC, de Melker HE, van Gageldonk PG, Schellekens JF, van der Klis FR, et al. (2010) Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis. PLoS One 5: e14183.
20. de Greeff SC, Mooi FR, Schellekens JF, de Melker HE, (2008) Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 27: 218-223.
21. Inatsuka CS, Xu Q, Vujkovic-Cvijin I, Wong S, Stibitz S, et al. (2010) Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun 78: 2901-2909.
22. Vincent JM, Cherry JD, Nauschuetz WF, Lipton A, Ono CM, et al. (2000) Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation. Clin Infect Dis 30: 534-539.
23. Isacson J, Trollfors B, Taranger J, Lagergard T, (1995) Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr Infect Dis J 14: 517-521.
24. Cherry JD, Beer T, Chartrand SA, DeVille J, Beer E, et al. (1995) Comparison of values of antibody to Bordetella pertussis antigens in young German and American men. Clin Infect Dis 20: 1271-1274.
25. von Linstow ML, Pontoppidan PL, von Konig CH, Cherry JD, Hogh B, (2010) Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children. Eur J Pediatr 169: 1119-1122.
26. Brandtzaeg P, (2007) Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann N Y Acad Sci 1098: 288-311.
27. Zackrisson G, Lagergard T, Trollfors B, Krantz I, (1990) Immunoglobulin A antibodies to pertussis toxin and filamentous hemagglutinin in saliva from patients with pertussis. J Clin Microbiol 28: 1502-1505.
28. Franco MA, Angel J, Greenberg HB, (2006) Immunity and correlates of protection for rotavirus vaccines. Vaccine 24: 2718-2731.
29. Gonzalez R, Franco M, Sarmiento L, Romero M, Schael IP, (2005) Serum IgA levels induced by rotavirus natural infection, but not following immunization with the RRV-TV vaccine (Rotashield), correlate with protection. J Med Virol 76: 608-612.
30. Buisman AM, Abbink F, Schepp RM, Sonsma JA, Herremans T, et al. (2008) Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly. J Infect Dis 197: 698-706.
31. Hanson LA, Korotkova M, (2002) The role of breastfeeding in prevention of neonatal infection. Semin Neonatol 7: 275-281.
32. Brandtzaeg P, (1995) The role of humoral mucosal immunity in the induction and maintenance of chronic airway infections. Am J Respir Crit Care Med 151: 2081-2086; discussion 2086-2087.
33. Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR, van de Winkel JG, (2001) Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect Immun 69: 4846-4850.
34. Wolfe DN, Kirimanjeswara GS, Goebel EM, Harvill ET, (2007) Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infect Immun 75: 4416-4422.
35. Feunou PF, Kammoun H, Debrie AS, Mielcarek N, Locht C, (2010) Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine 28: 7047-7053.